The Thermo Fisher Scientific - Artificial collaboration agreement enables direct integration of Thermo Fisher’s software and robotics platforms with Artificial’s software, maximizing the COVID-19 testing throughput and efficiency.

Today, Artificial announced the addition of Dr. Yvonne Linney to its Board of Directors and executive leadership team as Chief Operating Officer (COO).

As a distributed team before COVID-19, Artificial knows the importance of building tools that enhance productivity and efficient communication even when you aren’t physically in an office.